BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 26368591)

  • 21. [Heparin-induced type II thrombocytopenia--new views on diagnosis and therapy].
    Antonijević N; Stanojević M; Milosević R; Miković D; Kovac M; Terzić B; Vasiljević Z
    Med Pregl; 2003; 56(5-6):247-50. PubMed ID: 14565048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin-induced thrombocytopenia: recent experience in a large teaching hospital.
    Sturtevant JM; Pillans PI; Mackenzie F; Gibbs HH
    Intern Med J; 2006 Jul; 36(7):431-6. PubMed ID: 16780449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The approach to heparin-induced thrombocytopenia.
    Linkins LA; Warkentin TE
    Semin Respir Crit Care Med; 2008 Feb; 29(1):66-74. PubMed ID: 18302088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agents for the treatment of heparin-induced thrombocytopenia.
    Warkentin TE
    Hematol Oncol Clin North Am; 2010 Aug; 24(4):755-75, ix. PubMed ID: 20659659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin-induced thrombocytopenia: a common complication in cardiac transplant recipients.
    Hourigan LA; Walters DL; Keck SA; Dec GW
    J Heart Lung Transplant; 2002 Dec; 21(12):1283-9. PubMed ID: 12490273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis and treatment of heparin-induced thrombocytopenia (HIT) based on its atypical immunological features].
    Miyata S; Maeda T
    Rinsho Ketsueki; 2016 Mar; 57(3):322-32. PubMed ID: 27076245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Heparin induced thrombocytopenia].
    Brenske M; Tarnow J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Jul; 33(7):411-6. PubMed ID: 9728258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin-induced thrombocytopenia: diagnosis and management.
    Hassell K
    Thromb Res; 2008; 123 Suppl 1():S16-21. PubMed ID: 18829068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of liver transplantation in a patient with a history of heparin-induced thrombocytopenia.
    Fretschner R; Dietrich K; Unertl K; Greinacher A
    Transpl Int; 2005 Jun; 18(6):664-7. PubMed ID: 15910290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin-induced thrombocytopenia: clinical manifestations and management strategies.
    Menajovsky LB
    Am J Med; 2005 Aug; 118 Suppl 8A():21S-30S. PubMed ID: 16125511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin-induced thrombocytopenia: natural history, diagnosis, and management.
    Deitcher SR; Carman TL
    Vasc Med; 2001; 6(2):113-9. PubMed ID: 11530963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is the potential for overdiagnosis of heparin-induced thrombocytopenia?
    Lo GK; Sigouin CS; Warkentin TE
    Am J Hematol; 2007 Dec; 82(12):1037-43. PubMed ID: 17722079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serologic results in >1000 patients with suspected heparin-induced thrombocytopenia.
    Shelat SG; Tomaski A; Pollak ES
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):410-4. PubMed ID: 17895512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The HIT treatment in a cardiac surgery patient.
    Anna N; Boyan T; Kader MA; Catherine M; Matthias K
    Int J Cardiol; 2010 Oct; 144(3):405-7. PubMed ID: 19324432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High sensitivity and specificity of a new functional flow cytometry assay for clinically significant heparin-induced thrombocytopenia antibodies.
    Garritsen HS; Probst-Kepper M; Legath N; Eberl W; Samaniego S; Woudenberg J; Schuitemaker JH; Kroll H; Gurney DA; Moore GW; Zehnder JL
    Int J Lab Hematol; 2014 Apr; 36(2):135-43. PubMed ID: 23981347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
    Demma LJ; Winkler AM; Levy JH
    Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin-induced thrombocytopenia: pathophysiology and new treatment options.
    Harenberg J; Jörg I; Fenyvesi T
    Pathophysiol Haemost Thromb; 2002; 32(5-6):289-94. PubMed ID: 13679659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update in hematology: heparin-induced thrombocytopenia and bivalirudin.
    Augoustides JG
    J Cardiothorac Vasc Anesth; 2011 Apr; 25(2):371-5. PubMed ID: 21316987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and management of heparin-induced thrombocytopenia.
    de Maistre E; Gruel Y; Lasne D
    Can J Anaesth; 2006 Jun; 53(6 Suppl):S123-34. PubMed ID: 16766786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging Role of Direct Oral Anticoagulants in the Management of Heparin-Induced Thrombocytopenia.
    Tran PN; Tran MH
    Clin Appl Thromb Hemost; 2018 Mar; 24(2):201-209. PubMed ID: 28301915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.